Ophthalmology

Rathinam SR, Babu M, Thundikandy R, Kanakath A, Nardone N, Esterberg E, Lee SM, Enanoria WT, Porco TC, Browne EN, Weinrib R, Acharya NR. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology. 2014 Oct;121(10):1863-70. doi: 10.1016/j.ophtha.2014.04.023


OBJECTIVE: To compare the relative effectiveness of methotrexate and mycophenolate mofetil for noninfectious intermediate uveitis, posterior uveitis, or panuveitis.

DESIGN: Multicenter, block-randomized, observer-masked clinical trial.

Park J, Covert D, Fairchild C, Brubaker M, Martin SA, Lewis S, DeMuro C. Development of an eye drop comfort measure for topical ocular drop application. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 24, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A364.


OBJECTIVE: To develop a new patient-reported outcomes (PRO) measure assessing the comfort of topical ocular drop applications - the Eye Drop Comfort Scale (EDCS) in an adult population who have an ophthalmologic condition.

Herring W, Carrico J, Mladsi D, Pierson RF, Lofland JH. A review of vision-related utility values and their suitability for use in cost-effectiveness models in age-related macular degeneration. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 22, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A159.


Margulis AV, Houben E, Hallas J, Overbeek JA, Pottegard A, Torp-Pedersen T, Perez-Gutthann S, Arana A. Ophthalmic nepafenac use in the Netherlands and Denmark. Acta Ophthalmol. 2017 Aug;95(5):509-17. doi: 10.1111/aos.13468


PURPOSE:  To describe nepafenac use in the Netherlands and Denmark with reference to its approved indications. For context, we also describe the use of ketorolac and diclofenac.

Margulis A, Houben E, Olesen M, Hallas J, Overbeek J, Pottegard A, Ye W, Villegas D, Perez-Gutthann S, Arana A. Drug utilization study: evaluation of the use of nepafenac in the Netherlands and Denmark. Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):225.


Herring W, Mladsi DM. External validation of health economic models for complex chronic diseases: lessons from a population model for diabetic retinopathy. Poster presented at the 2016 ISPOR 21st Annual International Meeting; May 23, 2016. Washington, DC. [abstract] Value Health. 2016 May; 19(3):A88.


Astier P, Arana A, Oterino D, Lopez MA, Piero S. Cost analysis for the different strategies in cataract surgery. Presented at the V Congreso de la Sociedad Española de Salud Pública y Administración Sanitaria; 1993. Granada, Spain.


Abstract not available at this time.

Fortuny J, Leteneux-Pantias C, Xu X, Plana E. Prevalence and incidence of pathologic myopia and retinal neovascularization in a US managed care database. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, United States. [abstract] Value Health. 2013 May; 16(3):A176.


OBJECTIVES: The epidemiology of pathologic myopia (PM), an important cause of visual impairment worldwide, is poorly understood. This study analyzed data from a large US claims database to estimate the prevalence and incidence of PM and PM + retinal neovascularization (RNV).

Arana A, Arellano FM, Rivero E, Pavesi M, Dey D, Wentworth CW. Intravitreal (IVT) injection-related ocular adverse events in the general population of the United States of America. Poster presented at the 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2008. Copenhagen, Denmark. [abstract] Pharmacoepidemiol Drug Saf. 2008 Aug; 17(Suppl 1):S75-6.


Abstract not available at this time.

Herring WL, Grant TJ, Mladsi DM. A mathematical model to estimate the health benefits and costs of diabetic retinopathy screening programs. Presented at the 2015 Institute for Operations Research and Management Science Computing Conference; January 12, 2015. Richmond, VA.


Subscribe to Ophthalmology

How Can We Help You?